The 7 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +56.95% increase from the last price of 4.46.
The current consensus among 7 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.02
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.